Abbott Laboratories (ABT) Company Profile & Statistics

Abbott Laboratories
ABT
(NYSE)
Closed
116.43
-0.37 (-0.32%)
in:usd•As of: Nov 12, 2024 15:59 UTC -5
After Market:116.27-0.16 (-0.14%)
Open
116.81
High
117.28
Low
116.43

About Abbott Laboratories

CEO

Robert B. Ford

Headquarters

100 abbott park road

abbott park, il 60064, united states

Auditor

Ernst & Young LLP

Employees

114,000

Share Holders

32,449

Website

www.abbott.com

Industry

medical specialties

Sector

health technology

Company Overview

Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson.

Abbott Laboratories Statistics

Valuation Measures

Market Capitalization ²	201.94B
Enterprise Value	201.94B
Enterprise Value/EBITDA (ttm)	27.82
Price to Earnings Ratio (ttm)	25.79
Price to Book (mrq)	5.05
Price to Sales (ttm)	4.91
Price to Cash (ytd)	18.33

Profitability

Gross Margin (ttm)	41.59%
Operating Margin (ttm)	19.28%
Profit Margin (ttm)	10.10%
Return on Equity (ttm)	20.18%
Return on Invested Capital (ttm)	7.88%
Return on Assets (ttm)	10.84%

Income Statement

Revenue (ttm)	41.22B
Revenue Per Share (ttm)	N/A
Gross Profit (ttm)	22.90B
EBITDA (ttm)³	7.26B
Net Income Avi to Common (ttm)	5.77B
Diluted EPS (ttm)	3.29

Share Statistics

Beta (5Y Monthly)	0.72
52-Week Change	23.97%
S&P500 52-Week Change	35.64%
S&P500 Member	Yes
Stock Optionable	Yes
Total Shares Outstanding ¹	N/A
Dividend Yield	1.89%
Float ⁴	1.72B
% Held by Insiders	1.10%
% Held by Institutions	75.18%

Balance Sheet

Total Cash (mrq)	0.00
Total Cash Per Share (mrq)	N/A
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	N/A
Quick Ratio (mrq)	1.14%
Book Value Per Share (mrq)	N/A

Cash Flow

Operating Cash Flow Per Share (ytd)	N/A
Free Cash Flow (ytd)	0.00

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Abbott Laboratories

Trade With A Regulated Broker